Login to Your Account



Upsher-Smith Nabs Proximagen in CVR-Based $555M Buyout

By Nuala Moran
Staff Writer

Thursday, June 14, 2012

LONDON – Proximagen Group plc has fallen into the arms of its long-term partner and 16 percent shareholder, Upsher-Smith Laboratories Ltd., in a deal worth up to £356.8 million (US$554.7 million).

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription